Program Description: |
Advocate Lutheran General Hospital's stem cell transplant program provides adult autologous and related-allogeneic transplants for hematological malignancies such as Leukemia, Myeloma and Lymphoma. Collectively, our physicians have more than 65 years of transplant experience, and we offer expert and personalized care with a dedicated team of nurses, pharmacists, nutritionists, and physical and occupational therapists. |
Contact Information: |
This information is currently unavailable. |
Program Type: |
Adults only |
Attending Physicians:
(Medical Doctors) |
Adult - Leonard M. Klein, Jacob D. Bitran, Chadi Nabhan, John Eklund, David Hakimian, Pamela Kaiser |
Transplants Performed: |
Marrow/PBSC |
Cord blood transplants performed on: |
Not performed |
Explain Transplant Center HLA Match Requirements
Estimated Search & Transplant Costs
The costs for a transplant vary greatly from center to center and depend
on factors such as health insurance, disease type and disease stage of
the patient, as well as center-specific billing policies. Examples of
costs in the search and transplant include:
- The amount and geographic location of donors tested
- Testing needed to confirm a match
- Processing and collecting of tissue-typing samples
- Donor workup testing needed
- Getting the marrow, PBSC or cord blood unit for transplant
For the best understanding of costs of transplant and follow-up for a
specific transplant center, contact the center's Financial Representative.
Explain Transplant Costs at Different Centers
Financial Services:
Financial services at this center could include:
- Health insurance information
- Financial assistance
- Patient-related resources
|
Resources for financial information
If you have questions about costs and financial services at this
transplant center, you can contact the center's financial
representative.
Many organizations exist to help patients with lodging, transportation and
other transplant-related expenses. Visit the National Marrow Donor Program's
Patient Organizations database
for more information. Financial assistance resources are also listed
on this Web site.
|
Center-Specific Analysis
This analysis includes ONLY patients who received their FIRST ALLOGENEIC* transplant
between January 1, 2008 and December 31, 2010 using unrelated or related donors, and
who had at least a 100-day follow-up.
- This center reported survival status data for 6 patients.
- The actual one-year survival of these patients is 67%.
- Based on a national average for patients like those transplanted at this center, 95% of the time the one-year survival is expected to be between 42% and 100% for patients at this center.
- This center's actual results are similar to the expected range for this center.
*Allogeneic means using cells from a person other than the patient.
For help with understanding these statistics, please see Understanding Transplant Outcomes (PDF).
Survival by Patient's Age, Disease Type and Stage
If you do not find your disease in the statistics below, it may be combined with other similar diseases in a category. Please refer to our broad disease categories page for more information.
Further information about this center, including the number and type of
transplants performed in each of the last three years, and the support groups
offered, may be found in the BMT InfoNet Transplant Center Directory:
http://www.bmtinfonet.org/transplantcenters.
BMT InfoNet (Blood & Marrow Transplant Information Network) is a
nonprofit organization that provides information and emotional support
to transplant patients and their families.
Please take a
brief
survey to share your feedback on the transplant center informational listings.